Expression of Lewis-related antigen and prognosis in stage I non—small cell lung cancer
The Annals of Thoracic Surgery, ISSN: 0003-4975, Vol: 59, Issue: 2, Page: 412-415
1995
- 39Citations
- 14Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations39
- Citation Indexes39
- 39
- CrossRef28
- Captures14
- Readers14
- 14
Article Description
Immunohistochemical expression of Lewis y, sialyl Lewis x, and sialyl Lewis a were examined in relation to blood vessel invasion and prognosis in 133 patients with stage I non—small cell lung cancer who had a curative resection from 1980 to 1991. Expression of sialyl Lewis x in adenocarcinomas was higher than in squamous cell and large cell carcinomas, and Lewis y immunoreactivity was the highest among the three antigens. The frequency of blood vessel invasion was significantly higher in tumors with expression of Lewis y or sialyl Lewis antigen (sialyl Lewis x or sialyl Lewis a ), however, Lewis y expression was even more significant. The postoperative survival was significantly shorter when tumors expressed both the Lewis y and sialyl Lewis antigen. However, the survival of patients with either Lewis y or sialyl Lewis antigen expression was similar to that of patients whose tumors did not express either the Lewis y or sialyl Lewis antigens. These results suggest that Lewis y and sialyl Lewis antigen may be of prognostic value for metastatic potential but have different functional roles in tumor cells.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/0003497594008666; http://dx.doi.org/10.1016/0003-4975(94)00866-6; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0028877681&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/7847958; https://linkinghub.elsevier.com/retrieve/pii/0003497594008666
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know